[HTML][HTML] Managing the coagulopathy associated with cardiopulmonary bypass

J Bartoszko, K Karkouti - Journal of Thrombosis and Haemostasis, 2021 - Elsevier
Cardiopulmonary bypass (CPB) has allowed for significant surgical advancements, but
accompanying risks can be significant and must be expertly managed. One of the foremost …

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors

SJ Connolly, M Crowther, JW Eikelboom… - … England Journal of …, 2019 - Mass Medical Soc
Background Andexanet alfa is a modified recombinant inactive form of human factor Xa
developed for reversal of factor Xa inhibitors. Methods We evaluated 352 patients who had …

Gastrointestinal bleeding risk with direct oral anticoagulants

R Benamouzig, M Guenoun, D Deutsch… - … Drugs and Therapy, 2022 - Springer
Purpose Although direct oral anticoagulants (DOACs) are associated with an overall
favourable safety profile, the risk of gastrointestinal bleeding with DOACs compared with …

[HTML][HTML] Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis

F Migliorini, N Maffulli, E Velaj, A Bell… - Journal of Orthopaedics …, 2024 - Springer
Background Several clinical investigations have compared different pharmacologic agents
for the prophylaxis of venous thromboembolism (VTE). However, no consensus has been …

Fibrinogen, coagulation, and ageing

R Donkin, YL Fung, I Singh - Biochemistry and cell biology of ageing: part …, 2023 - Springer
Abstract The World Health Organization estimates that the world's population over 60 years
of age will nearly double in the next 30 years. This change imposes increasing demands on …

Dry needling and antithrombotic drugs

M Muñoz, J Dommerholt… - Pain Research and …, 2022 - Wiley Online Library
Many clinicians increasingly use dry needling in clinical practice. However, whether patients'
intake of antithrombotic drugs should be considered as a contraindication for dry needling …

Hemadsorption for removal of ticagrelor and direct oral anticoagulants in cardiac surgery

R Jackson, RM Trus, M El-Diasty - Expert Review of …, 2022 - Taylor & Francis
Introduction Cardiac patients on antiplatelets or oral anticoagulation undergoing emergent
cardiac surgery without appropriate washout periods are at increased risk for developing …

Evidence-based Management of Major Bleeding in patients receiving direct oral anticoagulants: an updated narrative review on the role of specific reversal agents

Z Al Aseri, FH AlGahtani, MF Bakheet… - Journal of …, 2023 - journals.sagepub.com
The indications of direct oral anticoagulants (DOACs) have expanded over the past 15
years. DOACs are effective and safe oral anticoagulants associated with lower bleeding …

Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice

S Heuts, A Ceulemans, GJ Kuiper… - European Journal of …, 2023 - academic.oup.com
OBJECTIVES Literature is scarce on the management of patients using direct oral
anticoagulants (DOACs) undergoing elective, urgent and emergency surgery. Therefore, we …

[HTML][HTML] Rivaroxaban

R Singh, PD Emmady - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Identify the indications of rivaroxaban therapy. Describe the mechanism of action
of rivaroxaban. Outline the contraindications in a patient on rivaroxaban therapy. Review the …